Breast Cancer Trial, Recruiting NCT06984250 Sponsor: National Taiwan University Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06984250
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are female and have been diagnosed with early-stage breast cancer (a smaller tumour that has not spread extensively to lymph nodes) or a non-invasive breast condition called ductal carcinoma in situ (DCIS), confirmed by a tissue biopsy.
  • People who are having surgery to remove the tumour while keeping most of the breast (rather than full breast removal).
  • People who are 20 years of age or older.
  • People whose general health and ability to carry out daily activities meets a minimum level, as measured by a standard medical scoring scale (confirm with trial site).
  • People with a life expectancy of at least 5 years.
  • People whose kidneys and liver are functioning adequately.

Who may not be able to join:

  • People who are pregnant.
  • People who have previously had radiation treatment to the chest area and would need radiation delivered to that same region again.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 88697255451

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 February 2025
Est. completion
28 February 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Ipsilateral breast tumor recurrence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov